Verrica Pharmaceuticals Inc. (VRCA) Executive Compensation
Verrica Pharmaceuticals Inc. (VRCA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VRCA
CIK: 1660334
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerGretchen Pinto
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-18 | 2026-08-17 | 4 Filing | 0002046750-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0002043558-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 Filing | 0001579649-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-18 | 4 Filing | 0001556327-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001660334-26-000025 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338273 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001814892-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001814338-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001257544-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001579649-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0002046750-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0002043558-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001745995-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | 8-K | 0001193125-26-263722 | View SEC Doc Filr Page |
| S-8 | 2026-05-12 | — | S-8 | 0001193125-26-219912 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001660334-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-219395 | View SEC Doc Filr Page |
| ARS | 2026-04-20 | 2025-12-31 | ARS | 0001193125-26-164036 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-20 | — | DEFA14A | 0001193125-26-164025 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-20 | 2026-06-05 | DEF 14A | 0001193125-26-163961 | View SEC Doc Filr Page |
| 10-K | 2026-03-11 | 2025-12-31 | 10-K | 0001660334-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-03-11 | 2026-03-11 | 8-K | 0001193125-26-101126 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001172661-26-001229 | View SEC Doc Filr Page |
| 3/A | 2026-02-02 | 2025-11-25 | 3/A Filing | 0002101167-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-29 | — | SCHEDULE 13G/A Filing | 0001315863-26-000100 | View SEC Doc Filr Page |